Stratec (ETR:SBS) Trading Down 4.2% – What’s Next?

Stratec SE (ETR:SBS)’s stock price dropped 4.2% during mid-day trading on Friday . The stock traded as low as €19.50 and last traded at €19.60. Approximately 27,883 shares changed hands during trading, an increase of 346% from the average daily volume of 6,253 shares. The stock had previously closed at €20.45.

Stratec Stock Performance

The company has a debt-to-equity ratio of 66.97, a current ratio of 2.52 and a quick ratio of 1.65. The firm has a market cap of $235.47 million, a price-to-earnings ratio of 23.52, a P/E/G ratio of 10.43 and a beta of 0.16. The firm has a fifty day simple moving average of €22.31 and a two-hundred day simple moving average of €24.72.

About Stratec

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.